Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2010
03/31/2010EP2169067A1 Recombinant production of serum albumin
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168977A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
03/31/2010EP2167665A1 A method of enhancing recombinant protein production
03/31/2010EP2167650A1 Cho cell
03/31/2010EP1687328B1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
03/31/2010EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins
03/31/2010CN101688229A Treatment method using egfr antibodies and src inhibitors and related formulations
03/31/2010CN101688228A Methods for generation of antibodies
03/31/2010CN101688195A Method for production of recombinant human thrombin `644
03/31/2010CN101688182A Immortalized avian cell lines
03/31/2010CN101688181A CHO cell
03/31/2010CN101688179A Recombinant protein production in avian ebx r cells
03/31/2010CN101687930A Chimeric and humanized anti-CD44 antibodies that mediate cancer cell cytotoxicity
03/31/2010CN101687035A Novel compounds
03/31/2010CN101687031A Compositions and methods for treating ocular diseases and conditions
03/31/2010CN101684471A Biological synthesis gene cluster of nocathiacins
03/31/2010CN101684160A Recombinant protein for diagnosing bovine tuberculosis and application thereof
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684157A anti-ox40l antibodies
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684148A Novel surface protein of neisseria meningitidis
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684146A Novel hcv non-structural polypeptide
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687242 KID31 and antibodies that bind thereto
03/30/2010US7687061 Method of modulating the activity of functional immune molecules to Her-2
03/30/2010CA2428642C Methods for large scale production of recombinant dna-derived tpa or k2s molecules
03/30/2010CA2409347C Enhanced protein thermostability and temperature resistance
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/30/2010CA2144223C Effector proteins of rapamycin
03/25/2010WO2010033913A1 Antibodies, analogs and uses thereof
03/25/2010WO2010032492A1 Koji mold alkaline protease promoter
03/25/2010WO2010014854A3 Antibodies that neutralize botulinum neurotoxins
03/25/2010WO2009131919A8 Polymerases for incorporating modified nucleotides
03/25/2010US20100077508 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077507 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077494 Ungulates with Genetically Modified Immune Systems
03/25/2010US20100076180 Method of fixing rail molecule and nano transport device
03/25/2010US20100076177 Hybrid antibodies
03/25/2010US20100076176 Sweetener Preparations and Methods of Use
03/25/2010US20100075902 Recombinant XRGD-Enriched Gelatins Having High Stability
03/25/2010US20100075402 DNA coding for polypeptide fusion
03/25/2010US20100075380 Novel Lipase
03/25/2010US20100075379 Method for making polyalkylene oxide modified hemoglobin
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100075377 Tetramerizing polypeptides and methods of use
03/25/2010US20100075376 DNase Expression in Recombinant Host Cells
03/25/2010US20100075375 Methods for the purification of polypeptide conjugates
03/25/2010US20100075374 Methods for capturing nascent proteins
03/25/2010US20100075343 Novel peptides
03/25/2010US20100074991 Novel oxidoreductases and uses thereof
03/25/2010US20100074924 Membrane protein sm29 of schistosoma mansoni and uses thereof for treating and diagnosing schistosomiasis
03/25/2010US20100074916 Avian influenza vaccine
03/25/2010US20100074915 Chimeric influenza virus-like particles
03/25/2010US20100074906 Antibodies Specific for Varicella Zoster Virus
03/25/2010US20100074901 Human anti-amyloid antibodies, compositions, methods and uses
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074893 ECM-Complex Antibody Compositions and Methods of Use
03/25/2010US20100074874 Synthetic multi-layer structures comprising biopolymer fibres
03/25/2010US20100074869 Multifunctional Cytokines
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/24/2010EP2166109A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
03/24/2010EP2165714A1 Humanized antibodies recognizing the beta-amyloid peptide
03/24/2010EP2164956A2 Tat signal peptides for producing proteins in prokaryotes
03/24/2010EP2164874A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN101680014A glycosylation of molecules
03/24/2010CN101679992A Expression system
03/24/2010CN101679989A Methods and compositions for enhanced protein expression and purification
03/24/2010CN101679968A Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
03/24/2010CN101679966A Genetically recombinant antibody composition having enhanced effector activity
03/24/2010CN101679965A Endoglucanase ppce and cellulase preparation containing the same
03/24/2010CN101679958A Tat signal peptides for producing proteins in prokaryotes
03/24/2010CN101679943A Use of low temperature and/or low ph in cell culture
03/24/2010CN101679941A Use of copper and glutamate in cell culture for production of polypeptides
03/24/2010CN101679934A Production of glycoproteins with modified fucosylation
03/24/2010CN101679526A Humanized and chimeric anti-TROP-2 antibodies that mediate cancer cell cytotoxicity
03/24/2010CN101679507A crystalline anti-human il-12 antibodies
03/24/2010CN101679506A Compositions and methods for binding sphingosine-1-phosphate
03/24/2010CN101679502A A new type of consensus interferon and preparation method thereof
03/24/2010CN101679498A bis-met histones
03/24/2010CN101679491A insecticidal proteins
03/24/2010CN101679489A A modified secretion system to increase expression of polypeptides in bacteria
03/24/2010CN101677537A disintegrin variants and pharmaceutical uses thereof
03/24/2010CN101676728A cytokine receptor
03/24/2010CN101676401A Scorpion peptide and preparation method
03/24/2010CN101676400A Expression of biologically active polypeptides in duckweed
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676388A Avian cell lines for the production of useful substances
03/24/2010CN101676384A Method for simultaneously producing glutathione and S-adenosyl methionine at high yield
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use
03/24/2010CN100594798C Method for preparing dope using fresh water fishbone
03/23/2010US7682619 comprising hemaggluttinin gene; host cells
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 1125